The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Centinel Spine sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Centinel Spine Inc (Centinel Spine) is a medical device company that manufactures and markets spinal devices. The company develops integrated interbody fusion technologies. It offers lumbar and cervical solutions. Centinel Spine’s product includes ALTOS, a posterior cervical thoracic stabilization system for use in lateral masses of the cervical spine or the pedicles of the cervical-thoracic spine. The company offers simple implants and instruments that spare tissue and generate better clinical outcomes. It operates through its offices in West Chester and New York, the US. Centinel Spine is headquartered in West Chester, Pennsylvania, the US.
The key metrics of Centinel Spine related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Centinel Spine is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Centinel Spine.
For a detailed understanding of the performance of Centinel Spine, buy the report here.